NHMRC - Other Schemes

Status

OPEN

Funding body

National Health and Medical Research Council

Internal deadlines

Stage REQ'D? SUBMISSION
NHMRC-European Union Collaborative Research Grants for funding commencing in 2017
Submit Notice of Intent to Submit (NOIS) form M ASAP
Email Deakin Research Grants
Applications open in RGMS
25 Jan 2017
Final application in RGMS and Certification forms M 15 Feb 2017
Email snapshot reports and all uploaded documents to Deakin NHMRC Submissions



Global Alliance for Chronic Diseases (GACD): prevention and management of mental disorders
Submit Notice of Intent to Submit (NOIS) formM24 Jan 2017
Email Deakin Research Grants
Applications open in RGMS
18 Jan 2017
Final application in RGMS and Certification formsM15 Feb 2017
Email snapshot reports and all uploaded documents to Deakin NHMRC Submissions



NHMRC/A*STAR Joint Call for Research in Novel Molecular Mechanisms of Obesity and Metabolic Diseases
Submit Notice of Intent to Submit (NOIS) formM6 Jan 2017
Email Deakin Research Grants
Applications open in RGMS
25 Jan 2017
Final application in RGMS and Certification formsM1 March 2017
Email snapshot reports and all uploaded documents to Deakin NHMRC Submissions



Boosting Dementia Research Grants - Priority Round 2: JPND Call for Multinational Research Projects for Pathway Analysis across Neurodegenerative Diseases
Submit Notice of Intent to Submit (NOIS) formM10 Feb 2017
Email Deakin Research Grants
Final pre-proposal application (refer to JPND website for further details) and Certification formsM20 Feb 2017
Email Deakin Research Grants
Applications open in RGMS
21 Jun 2017
Final application in RGMS (only required if pre-proposal invited by JPND to submit a full proprosal) M05 Jul 2017
Email snapshot reports and all uploaded documents to Deakin NHMRC Submissions



NHMRC-European Union Collaborative Research Grants for funding commencing in 2018
Submit Notice of Intent to Submit (NOIS) form M Aug 2017
Email Deakin Research Grants
Applications open in RGMS
Oct 2017 (TBC)
Final application in RGMS and Certification forms M Late Oct 2017 (TBC)
Email snapshot reports and all uploaded documents to Deakin NHMRC Submissions

O - Optional / M - Mandatory

Overview

NHMRC-European Union Collaborative Research Grants commencing in 2017

The National Health and Medical Research Council (NHMRC)-European Union (EU) Collaborative Research Grants scheme aims to provide assistance to Australian researchers to participate in multinational research collaborative projects with international researchers that have been selected for funding under the European Commission’s Horizon 2020.

Projects involving Australian researchers based in Australia that are chosen by the European Commission (EC) for funding, may be eligible for NHMRC support of up to $500,000.

Applications will only be eligible for NHMRC Support if they have been submitted to the European Commission and has been successful through the EU process under the following  Horizon 2020- Societal Challenges – Health, Demographic Change and Wellbeing calls:

SC1-PM-18-2016: Big Data supporting Public Health policies;

SC1-PM-21-2016: Implementation research for scaling-up of evidence based innovations and good practice in Europe and low- and middle-income countries;

SC1-PM-04 -2016: Networking and optimising the use of population and patient cohorts at EU level;

SC1-PM-06-2016: Vaccine development for malaria and/or neglected infectious diseases;

SC1-PM-09-2016: New therapies for chronic diseases

or the following Food security, sustainable agriculture and forestry, marine and maritime and inland water research and the bioeconomy calls:

SFS-38-2016: Impulsivity and compulsivity and the link to nutrition, lifestyle and the socio-economic environment;

SFS-37-2016: The impact of consumer practices in food safety: risks and mitigation strategies

For more information, visit NHMRC scheme webpage.

Global Alliance for Chronic Diseases (GACD): prevention and management of mental disorders

The Global Alliance for Chronic Diseases (GACD) supports international and interdisciplinary collaborations in research, focusing on chronic non-communicable diseases. The work of the GACD focuses on the needs of low and middle income countries (LMICs) and vulnerable populations in more developed countries.

NHMRC is participating in a GACD Request for Applications (RFA) on the prevention and management of mental disorders in LMICs and Indigenous communities in high income countries.

This call will focus on implementation research proposals on child, adolescent and adult age onset mental disorders including, but not limited to, dementia, depression, schizophrenia, bipolar disorders, alcohol and drug use disorders, etc., in LMICs as defined by The World Bank, and Indigenous communities in high income countries. Full details of the aim, scope and assessment criteria of this call can be found on the GACD website.

As part of this call, NHMRC is encouraging applications that address the prevention and management of mental disorders in Aboriginal and Torres Strait Islander populations.

For more information, visit NHMRC scheme webpage.

NHMRC/A*STAR Joint Call for Research in Novel Molecular Mechanisms of Obesity and Metabolic Diseases in Singapore and Australia

A*STAR and NHMRC have allocated a total of up to $4 million (AUD) to support up to five collaborative research projects. Grants will be awarded for a total duration of three years.

Proposals must involve a genuine collaboration involving at least one research team from Singapore and Australia to be eligible. A research team must involve more than the two lead CIs. The research project requires joint input of both the Singapore and Australian teams.

Applicants will be required to submit two budgets with their proposal, a Singapore and an Australian budget. Applicants may request in their budget a maximum of $350,000 (AUD) for research conducted in Australia, and a maximum of $350,000 (SGD) for research conducted in Singapore in total over the life of the grant.

This joint call is for research into novel molecular mechanisms of obesity and metabolic diseases. The specific objectives of the joint call are to:

  • generate new knowledge that will lead to novel approaches to manage metabolic diseases and obesity to translate into policy and practice
  • foster co-investment with international partners in research programs of joint interest that will involve researchers based in Singapore and Australia
  • increase the level of scientific skills and technological capabilities between Singapore and Australia
  • build further collaborations between Singapore and Australian researchers.

This call will focus on molecular mechanisms of metabolic diseases characterised by high blood pressure, insulin resistance, high cholesterol or unhealthy weight gain/retention related to obesity including, but not limited to, genetics, epigenetics, genomics, neurobiology and microbiomes. This might include research to identify new biomarkers or new intervention targets.

This call will not fund research applications in the broad research area of public health, health services or health promotion and/or applications focussed primarily on: dietary interventions or research focused on nutritional science; cancer or cohort studies.

For more information, visit NHMRC scheme webpage

Boosting Dementia Research Grants - Priority Round 2: JPND Call for Multinational Research Projects for Pathway Analysis across Neurodegenerative Diseases

NHMRC’s Boosting Dementia Research Grants Scheme Priority Round 2 (PR2) aims to provide assistance to Australian researchers to participate in multinational collaborative research projects that have been selected for funding under the European Union Joint Programme – Neurodegenerative Disease (JPND): Call for Multinational Research Projects for Pathway Analysis across Neurodegenerative Diseases.

JPND is aimed at tackling the challenge of neurodegenerative diseases and coordinating investment into research to find causes, develop cures, and identify appropriate ways to care for those with neurodegenerative diseases. More information about this Call is available from the JPND website.

Under PR2, NHMRC will provide up to $850,000 of funding over a maximum period of three years for Australian-based researchers participating in multinational consortia that have been favourably reviewed by JPND.

Only research with a key focus on “Alzheimer’s disease or other dementias” will be funded through PR2. Applying for funding with any other focus under this call will not be supported through this scheme.

To be eligible for PR2 funding, Australian researchers must apply to the JPND as part of a collaborative application.

For more information, visit NHMRC scheme webpage

NHMRC-European Union Collaborative Research Grants commencing in 2018

The National Health and Medical Research Council (NHMRC)-European Union (EU) Collaborative Research Grants scheme aims to provide assistance to Australian researchers to participate in multinational research collaborative projects with international researchers that have been selected for funding under the European Commission’s Horizon 2020.

Projects involving Australian researchers based in Australia that are chosen by the European Commission (EC) for funding, may be eligible for NHMRC support of up to $500,000.

Applications will only be eligible for NHMRC Support if they have been submitted to the European Commission and has been successful through the EU process under the following  Horizon 2020 calls:

Societal Challenges – Health, Demographic Change and Wellbeing

  1. SC1-PM-02-2017: New concepts in patient stratification
  2. SC1-PM-07-2017: Promoting mental health and well-being in the young
  3. SC1-PM-10-2017: Comparing the effectiveness of existing healthcare interventions in the adult population
  4. SC1-PM-15-2017: Personalised coaching for well-being and care of people as they age
  5. SC1-PM-16-2017: In-silico trials for developing and assessing biomedical products
  6. SC1-PM-17-2017: Personalised computer modelisation and in-silico systems for well-being

Industrial Leadership – Nanotechnologies, Advanced Materials, Advanced Manufacturing and Processing, and Biotechnology calls:

  1. NMBP-13-2017: Cross-cutting KETs for diagnostics at the point-of-care
  2. NMBP-14-2017: Regulatory Science Framework for assessment of risk benefit ratio of Nanomedicines and Biomaterials
  3. NMBP-15-2017: Nanotechnologies for imaging cellular transplants and regenerative process in vivo

For more information, visit NHMRC scheme webpage.

How to apply

  1. Submit a Notice of Intent to Submit (NOIS) (DOC, 18.2KB) form by email to Deakin Research Grants
  2. Liaise with your faculty/SRC.
  3. Read the Funding Rules and Instructions to Applicants (Refer to NHMRC scheme webpage).
  4. Commence your online application in the NHMRC Research Grants Management System - RGMS.
  5. Work with your DR-Grants case manager.
  6. Organise relevant Certification forms, and AI consents (if applicable). 
  7. Final application must be on RGMS by Final application due date; email snapshot reports, certification forms, consents & all uploaded documents to Deakin NHMRC Submissions
  8. Please note that minimum data requirements must be met on RGMS by the NHMRC deadline. Applications that miss this deadline will not be able to submit an application to the NHMRC.